TLRY Stock Summary and Trading Ideas (Tilray Brands | NASDAQ:TLRY)

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Tilray Brands trades on the NASDAQ stock market under the symbol TLRY.

As of December 27, 2024, TLRY stock price declined to $1.43 with 37,726,702 million shares trading.

TLRY has a beta of 1.09, meaning it tends to be more sensitive to market movements. TLRY has a correlation of 0.04 to the broad based SPY ETF.

TLRY has a market cap of $1.29 billion. This is considered a Small Cap stock.

Last quarter Tilray Brands reported $200 million in Revenue and -$.01 earnings per share. This fell short of revenue expectation by $-19 million and exceeded earnings estimates by $.03.

In the last 3 years, TLRY traded as high as $9.08 and as low as $1.14.

The top ETF exchange traded funds that TLRY belongs to (by Net Assets): MJ, VHT, CNBS, DFIS, YOLO.

TLRY has underperformed the market in the last year with a return of -36.2%, while the SPY ETF gained +26.4%. In the last 3 month period, TLRY fell short of the market, returning -17.8%, while SPY returned +4.5%. However, in the most recent 2 weeks TLRY has outperformed the stock market by returning +20.2%, while SPY returned -1.2%.

TLRY support price is $1.42 and resistance is $1.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TLRY shares will trade within this expected range on the day.